Back
Catalyst Pharmaceuticals, Inc. Stock Predictions
Color-coded buy, sell, hold signals make stock decisions simple.
Get Your Free Stock Analysis Now
Buy
70
CPRX
Catalyst Pharmaceuticals, Inc.
Last Price:
$24.31
Seasonality Move:
16.6%
7 Day Trial
ALL ACCESS PASS
$
7
Know when to buy, sell, or hold. Rate Any Stock In Seconds
Get Your Free Stock Analysis NowCatalyst Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, Catalyst Pharmaceuticals, Inc. has on average historically risen by 36.7% based on the past 19 years of stock performance.
-
Catalyst Pharmaceuticals, Inc. has risen higher in 9 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 47.37%
-
Is Catalyst Pharmaceuticals, Inc. Stock Undervalued?The current Catalyst Pharmaceuticals, Inc. [CPRX] share price is $24.58. The Score for CPRX is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
CPRX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Catalyst Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Catalyst Pharmaceuticals, Inc. has on average historically risen by 36.7% based on the past 19 years of stock performance.
Catalyst Pharmaceuticals, Inc. Stock Rating
Buy
70
Catalyst Pharmaceuticals, Inc. (CPRX)
is a Buy
Is Catalyst Pharmaceuticals, Inc. overpriced?
-
Catalyst Pharmaceuticals, Inc. has risen higher in 9 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 47.37%
Catalyst Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
catalystpharma.com
52-Week Data
52-Week High:
26.58
52-Week Low:
19.05
Prediction Charts
Market Cap:
3B
Price in USD:
24.58
Volume:
923K
Beta:
1.05
Technical Analysis
SMA50:
23.38
SMA100:
22.04
SMA200:
22.21
52-Wk Change:
2.59%
Stock Predictions
-
Is Catalyst Pharmaceuticals, Inc. stock public?Yes, Catalyst Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Catalyst Pharmaceuticals, Inc. stock quote today?The Catalyst Pharmaceuticals, Inc. stock price is 24.58 USD today.
-
How to buy Catalyst Pharmaceuticals, Inc. stock online?You can buy Catalyst Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-12 | 22.64 | 23.22 | 23.31 | 22.21 |
| Jan-13 | 23.17 | 22.35 | 23.26 | 22.13 |
| Jan-14 | 22.35 | 23.17 | 23.25 | 22.30 |
| Jan-15 | 23.12 | 22.96 | 23.24 | 22.55 |
| Jan-16 | 22.99 | 22.70 | 23.17 | 22.68 |
| Jan-20 | 22.54 | 23.38 | 23.41 | 22.33 |
| Jan-21 | 23.33 | 24.13 | 24.15 | 23.26 |
| Jan-22 | 24.22 | 24.45 | 24.56 | 23.99 |
| Jan-23 | 24.34 | 23.58 | 24.60 | 23.57 |
| Jan-26 | 23.90 | 23.99 | 24.83 | 23.63 |
| Jan-27 | 24.14 | 24.07 | 24.28 | 23.68 |
| Jan-28 | 24.04 | 24.20 | 24.33 | 23.71 |
| Jan-29 | 24.18 | 24.58 | 24.60 | 24.05 |
| Jan-30 | 24.60 | 24.30 | 24.80 | 24.10 |
Catalyst Pharmaceuticals, Inc. Earnings
Catalyst Pharmaceuticals, Inc. Earnings Report: Per Share Catalyst Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Catalyst Pharmaceuticals, Inc. Forecast Revenue Growth
Catalyst Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Catalyst Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and an increase next year of $0.03 per share.
* Catalyst Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.